An Eight-Week Study to Evaluate the Safety and Efficacy of VSJ-110 Compared to Placebo in the Treatment of Dry Eye

ConditionDry Eye

Trial statusRecruiting

Trial phasePhase 2

Trial typeInterventional

Biological sexAll

Age18+

SponsorVanda Pharmaceuticals

About this trial

The purpose of this study is to determine the safety and efficacy of VSJ-110 compared to placebo in the treatment of dry eye.

Be at least 18 years of age of either gender and any race.

Provide written informed consent and sign the HIPAA form.

Be willing and able to follow all instructions and attend all study visits.

Use of any of the disallowed medications during the washout and study period.

160 Participants

are divided into 2 treatment groups

Vanda Pharmaceuticals

Lead sponsor